JMPHF (Leveljump Healthcare) Enterprise Value: $10.25 Mil (As of Jun. 30, 2026) ***


What is Leveljump Healthcare Enterprise Value?

Leveljump Healthcare JMPHF Enterprise Value is $10.25 Mil as of Jun. 30, 2026. The stock has 2 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Leveljump Healthcare's Enterprise Value is $10.25 Mil. Leveljump Healthcare's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $0.62 Mil. Therefore, Leveljump Healthcare's EV-to-EBIT ratio for today is 16.66.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Leveljump Healthcare's Enterprise Value is $10.25 Mil. Leveljump Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $1.41 Mil. Therefore, Leveljump Healthcare's EV-to-EBITDA ratio for today is 7.25.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Leveljump Healthcare's Enterprise Value is $10.25 Mil. Leveljump Healthcare's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $13.49 Mil. Therefore, Leveljump Healthcare's EV-to-Revenue ratio for today is 0.76.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Leveljump Healthcare's Enterprise Value is $10.25 Mil. Leveljump Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was $1.49 Mil. Therefore, Leveljump Healthcare's EV-to-OCF ratio for today is 6.89.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Leveljump Healthcare's Enterprise Value is $10.25 Mil. Leveljump Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was $0.92 Mil. Therefore, Leveljump Healthcare's EV-to-FCF ratio for today is 11.09.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Leveljump Healthcare  (OTCPK:JMPHF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Leveljump Healthcare's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=10.247/0.615
=16.66

Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
Leveljump Healthcare's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.62 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Leveljump Healthcare's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=10.247/1.414
=7.25

Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
Leveljump Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.41 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Leveljump Healthcare's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=10.247/13.491
=0.76

Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
Leveljump Healthcare's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.49 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Leveljump Healthcare's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=10.247/1.487
=6.89

Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
Leveljump Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.49 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Leveljump Healthcare's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10.247/0.924
=11.09

Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
Leveljump Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Leveljump Healthcare Enterprise Value Related Terms


Leveljump Healthcare Enterprise Value Historical Data

* Premium members only.

The historical data trend for Leveljump Healthcare's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leveljump Healthcare Enterprise Value Chart

Leveljump Healthcare Annual Data
Trend Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial 0.00 4.53 5.85 12.54 8.09

Leveljump Healthcare Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.25 8.09 8.48 8.69 7.21

JMPHF vs TMO, DHR, IDXX: Enterprise Value Comparison

For the Diagnostics & Research subindustry, Leveljump Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leveljump Healthcare Enterprise Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Leveljump Healthcare's Enterprise Value falls into.



Leveljump Healthcare Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Leveljump Healthcare's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Leveljump Healthcare's Enterprise Value for the quarter that ended in Sep. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $10.25 Mil mean?
Leveljump Healthcare (JMPHF) has a Enterprise Value of $10.25 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Leveljump Healthcare and its competitors.
Is Leveljump Healthcare's Enterprise Value too high?
Leveljump Healthcare's current Enterprise Value is $10.25 Mil.
How does Leveljump Healthcare's Enterprise Value compare to TMO and DHR?
Leveljump Healthcare's Enterprise Value of $10.25 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Leveljump Healthcare and its competitors. Leveljump Healthcare's current Enterprise Value is $10.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Enterprise Value of $10.25 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Enterprise Value is $10.25 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Enterprise Value is $10.25 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Leveljump Healthcare Business Description

Other Exchanges JUMP:Canada
Address 52 Scarsdale Road, Suite 207, Toronto, ON, CAN, M3B 2R7
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.